Challenges and opportunities in research funding for neurovascular diseases from a clinical researcher's perspective

Johanna Maria Ospel, Rosalie McDonough, Aravind Ganesh, Arshia Sehgal, Manon Kappelhof, Nima Kashani, Karin Klijn, Michael Hill, Jeffrey Saver, Mayank Goyal

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background & Purpose: Neurovascular research is underfunded, imposing substantial challenges on clinical researchers in the field of neurovascular diseases. We explored what physicians perceive to be the greatest challenges with regard to neurovascular research funding, and how they think the funding crisis in neurovascular research could be overcome. Methods: We performed an international, multi-disciplinary survey among physicians involved in the medical care of patients with neurovascular diseases. After providing their demographic data, physicians were asked closed-ended questions on their personal opinion regarding challenges in neurovascular research funding, and how these challenges could be overcome. Physicians also described in their own words what they perceived to be the biggest challenges in obtaining funding. Data were analyzed using descriptive statistics and response clustering. Results: Of 233 participating physicians (70.4% male,82.8% senior staff) from 48 countries, 217(97.4%) perceived the discrepancy between required and available funding to be a problem;172(73.8%) considered it a major problem. High competitiveness (61/118 available free text responses[51.7%]), time-consuming application processes (28/118[23.7%]) and administrative requirements (25/118[21.1%]) were identified as key obstacles. Traditional big funding agencies were perceived to be most capable of closing the neurovascular research funding gap, followed by specialty-specific organizations and industry, while philanthropy and crowdfunding were perceived to be less important. Conclusion: The gap between required and available funding was perceived to be a major problem in neurovascular research, with high competitiveness, time-consuming funding processes and excessive administrative requirements being the key obstacles to obtaining funding. Traditional funding agencies were perceived to be most capable of closing this funding gap.
Original languageEnglish
JournalInterventional neuroradiology
Early online date2022
DOIs
Publication statusE-pub ahead of print - 2022

Keywords

  • Neurovascular research
  • clinician-scientist
  • research funding

Cite this